Life Science Leader Magazine Supplements

CMO 2015

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link: https://lifescienceleadermag.epubxp.com/i/469672

Contents of this Issue

Navigation

Page 66 of 83

QUALITY RELIABILITY PRODUCTIVITY REGULATORY INNOVATION K E Y W W W.C M O L E A D E R S H I PA W A R D S .C O M 2015 CMO LEADERSHIP AWARDS WINNERS Company Profiles LIFESCIENCELEADER.COM THE CMO LEADERSHIP AWARDS 2015 67 DRUG TYPE: Pharmaceuticals DRUG TYPE: Pharmaceuticals DRUG TYPE: Pharmaceuticals DRUG LIFE CYCLE STAGES: Research & Development: Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production DRUG LIFE CYCLE STAGES: Research & Development: Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production Formulated Drug Production: Dosage Form Development DRUG LIFE CYCLE STAGES: Research & Development: Preclinical, Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production Formulated Drug Production: Dosage Form Development, Dosage Form Production "Helsinn is honored to receive this award covering eight important client-partnering categories. We believe this is a reflection of our continued efforts in quality management and our ability to deliver high quality products and services together with our partners. This award represents a crowning achievement for Helsinn Manufacturing and our 30-year history in pharmaceutical bulk drug manufacturing." "We have a quality culture that puts patient safety first. This shapes our behaviors and motivates us to improve and innovate. Our values read: We are Principled Think Differently and Deliver. Everything we do is about aligning ourselves with our customers' goals, and we passionately turn any challenge into a solution by working as a team. These awards reward a great team effort. Hovione people are amazing, and we're In It For Life! " "IDT helps companies fast-track products from early API synthesis and dosage form development & manufacture through to clinical trials. By accessing the Australian R&D Tax Incentive and Clinical Trial Notification programs, our customers can speed their product into clinical trials faster and access up to a 43.5% cash rebate on their R&D spend. We help our customers to reach their milestones quicker and to achieve more with their development funding." SERVICES & CAPABILITIES: cytotoxic & high potency compounds, dry powder inhalers devices, generics, hot melt extrusion, inhalation formulation, particle engineering, powders (non- sterile), spray d rying SERVICES & CAPABILITIES: aseptic fill/finish, capsules, controlled substances, cytotoxic & high potency compounds, generics, injectables, liquids, lyophilized products, non-sterile, solid dose, solutions & suspensions, sterile, sustained release, dedicated beta-lactam antibiotic API R&D and commercial manufacturing facility WALDO MOSSI general manager GUY VILLAX CEO PAUL MACLEMAN managing director CATEGORIES WON CATEGORIES WON CATEGORIES WON IDT Australia Ltd Boronia, Victoria, Australia www.idtaus.com.au +61398018888 Mark Rowlands mrowlands@idtaus.com.au Key locations: Adelaide, Australia; Melbourne, Australia Hovione Loures, Portugal www.hovione.com +351 21 9829362 Antonio Dinis adinis@hovione.com Key locations: Cork, Ireland; Loures, Portugal; New Jersey, U.S.A.; Taipa, Macau Helsinn Advanced Synthesis SA Biasca, Switzerland www.helsinn.com +41 91 873 94 00 Sandra Moro Sandra.Moro@Helsinn.com Key locations: Biasca, Switzerland

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CMO 2015